German Bionic Debuts Groundbreaking Power Suit for Nursing and Care Professionals in North America
mehr
Storys zum Thema Gesundheit / Medizin
- Sprache:
- Medien:
- Zeitraum:
- Zeitraum:Gesamt
Hearing loss company Acousia Therapeutics to present key learnings and data from lead development programs at US and European meetings in August and September
Tübingen, Germany (ots) - Acousia Therapeutics GmbH to share key learnings and data from its lead candidate development programs — clinical stage ACOU085 and late preclinical stage ACOU082 — during four presentations at industry and research meetings from August 29 to September 5. From August 29–31, Acousia ...
mehrRHEACELL announces “First Patient In”: EB-Haus in Salzburg, Austria starts pivotal study for stem cell therapy for severe forms of Epidermolysis bullosa that is longed for by those affected
mehrThe Medias Hospital is Raising the Bar for Interventional Oncology as an IASIOS Enrolled Centre
Burghausen/Germany (ots) - The Medias Hospital has officially enrolled in the accreditation program of IASIOS to further ensure highest quality standards in Interventional Oncology as an important aspect of oncological patient care. The Medias Hospital has taken the next step to committing to the highest standards when it comes to interventional oncology (IO) care and ...
mehrSuccessful transaction: Adragos Pharma has officially taken over Clinigen’s development unit, Lamda Laboratories near Athens, Greece
Munich / London / Athens (ots) - - Adragos on a growth path: Three locations in Europe and five globally - Acquisition strengthens Adragos' end-to-end integrated pharmaceutical product development service offering - Agreement on further product development activities for Clinigen Munich-based pharmaceutical contract ...
mehrThe world's first Extended Isolated Stopflow Limb Infusion (EISLI) to treat osteosarcoma results in complete remission
mehrSuccessful transaction: Adragos Pharma has officially taken over the Sanofi production site in Kawagoe, Japan
Munich / Paris / Tokyo (ots) - - Adragos Pharma now third largest pure-play CDMO in the Japanese market - Long-term agreement with Sanofi secures local healthcare supply Munich-based pharmaceutical contract manufacturer (CDMO) Adragos Pharma GmbH successfully completed the acquisition of one of Japan's leading ...
mehrMadeira's public health service SESARAM, EPERAM cooperates with EU project Smart4Health
Potsdam (Germany) (ots) - - Over 260,000 residents and travelers to Madeira Islands can use the digital health solution free of charge - Easy access to healthcare data from the public healthcare services, via a European electronic health record - the Smart4Health platform The Public Health Service of the Autonomous Region of Madeira - SESARAM, EPERAM - has successfully ...
mehrBlood Donation Day at R-Biopharm: Employees Help Save Lives
mehrBreakthrough - EUR 50 million investment for start-up BrainRepair UG / Pivotal trial on stem cell treatment for brain damage in newborns fully funded
mehrFlu tests from R-Biopharm also detect new virus variants
mehrStem cell therapy for “Butterfly disease” / RHEACELL receives ‘Partners in Progress Award’ from debra of America for Epidermolysis Bullosa research
mehrMetrics in Balance und DNA Talks schließen sich zusammen und betreten den europäischen Lifestyle-Markt unter einem neuen Namen: LifeTalks
mehrKlinik für Prostata-Therapie Heidelberg
Focal therapy for prostate cancer: Reliable diagnosis leads to gentle treatment
mehrbenfovir AG has reached another milestone by completing the first part of the Phase 1 trial testing transketolase inhibitor / benfo-oxythiamine (B-OT)
Darmstadt (ots) - benfovir AG, a German pharmaceutical company focused on developing small molecules against viral infections such as SARS-CoV-2, dengue and herpes virus, today announced that the first part of the Phase 1 clinical trial (BV-01-101/ EudraCT Number: 2021-005616-60.) designed to evaluate the safety, ...
mehrEuropean Society for Medical Oncology (ESMO)
ESMO 2022 - Great oaks grow from small acorns: oncology is committed to doing its part for sustainability
Paris (ots) - At ESMO 2022, 9-13 September, Paris, France, the premier cancer congress in Europe, which has gathered 28k participants from 167 countries, many discussions will be around sustainability, prevention and novel approaches which could soon become a reality in the clinic. - Late-breaking results elucidate ...
mehrR-Biopharm starts commercialization of the fully automated RIDA®UNITY system for real-time PCR in molecular diagnostic laboratories
mehrR-Biopharm is IVDR certified
mehrbenfovir Announces First Subjects Dosed in Phase 1 Clinical Trial of B-OT/ B-OT IS BEING DEVELOPED FOR THE TREATMENT OF VIRAL INFECTIONS
Darmstadt (ots) - benfovir AG has reached another major milestone by moving its first compound into clinical development with the start of a Phase 1 testing B-OT in healthy volunteers. benfovir AG, a German pharmaceutical biotechnology company focused on developing small molecules against viral infection such as ...
mehr- 2
R-Biopharm acquires Australian lab equipment manufacturer and molecular biology multiplex specialist AusDiagnostics
mehr R-Biopharm announces test to detect monkeypox virus
mehr- 2
World's first electronic respirator sterilising (corona)-viruses of all variants completely by UV-LED-radiation-effected RNA destruction
mehr HPDC Launches the World’s First All-in-One Supply Chain Management Solution for Advanced & Personalized Therapies
Munich/Nice (ots) - Hypertrust Patient Data Care (HPDC) today announced the global launch of its extended Hypertrust X-Chain supply chain management solution for Advanced & Personalized Therapies (APT). It is the worldwide first solution that allows biotech and pharmaceutical companies to design, set up, plan, ...
mehrIs microplastic carcinogenic?
Graz/Vienna (ots) - The effects of micro- and nanoplastic particles (MNP) in the human body are being investigated in depth for the first time worldwide. From 2022 to 2025, research will be performed at CBmed together with international partners to elucidate potential health effects of microplastics. Every person in developed countries currently ingests an average of five grams of plastics per week - that's as much as a standard credit card. What these micro- and nanoplastic ...
mehrEndoscopic surgery of herniated discs demonstrates statistically significant pain relief and cost effectiveness compared to open procedures
Munich (ots) - A team of physicians, led by neurosurgeon Dr. B.S. Harhangi from Erasmus Medical Center in Rotterdam, recently published a study demonstrating considerable relief for patients with herniated discs after using the MaxMoreSpine© System. For the first time, a scientific study compares outcome and ...
mehr- 2
Exclusive Health & Safety Partner of the Munich Security Conference 2022: EcoCare commissioned to carry out daily COVID-19 tests on top politicians and diplomats
mehr COVID-19 Testing Without Having to Wait in line: A German Startup Shows How it Works
mehrUniversity of Chicago Clinical Trial Utilizes Sysmex Inostics Highly Effective HPV-SEQ Test to Measure HPV-DNA from Blood of Neck and Throat Cancer Patients
Baltimore, MD (ots) - Sysmex Inostics, a global leader in the liquid biopsy revolution for oncology, announces the use of their HPV-SEQ test in the prospective University of Chicago clinical trial,1 “Pilot Study of Chemotherapy for HPV-Associated Oropharyngeal Cancer.” “The ability to reliably detect HPV-DNA ...
mehrNew therapeutic approach against SARS-CoV-2 successfully tested
Pfungstadt (ots) - - Scientists at the Universities of Frankfurt a.M. and Kent (UK) have identified a metabolic pathway (pentose-phosphate pathway) that is crucial for the propagation of the SARS-CoV-2 virus in human cells. - The compound benfo-oxythiamine, an inhibitor of this metabolic pathway, has succeeded in blocking the replication of the SARS-CoV-2 virus in human cells. - Preclinical testing of this compound has ...
mehr- 2
R-Biopharm receives approval of COVID-19 test in the UK under CTDA legislation
mehr
Vorherige12345678910Nächste